DK0714897T3 - Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet - Google Patents

Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet

Info

Publication number
DK0714897T3
DK0714897T3 DK94922382T DK94922382T DK0714897T3 DK 0714897 T3 DK0714897 T3 DK 0714897T3 DK 94922382 T DK94922382 T DK 94922382T DK 94922382 T DK94922382 T DK 94922382T DK 0714897 T3 DK0714897 T3 DK 0714897T3
Authority
DK
Denmark
Prior art keywords
ring
antagonist activity
cyclopentene derivative
endothelin antagonist
condensed heteroaromatic
Prior art date
Application number
DK94922382T
Other languages
English (en)
Inventor
Kiyofumi Ishikawa
Toshio Nagase
Toshiaki Mase
Takashi Hayama
Masaki Ihara
Masaru Nishikibe
Mitsuo Yano
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/165,880 external-priority patent/US5389620A/en
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Application granted granted Critical
Publication of DK0714897T3 publication Critical patent/DK0714897T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK94922382T 1993-08-18 1994-08-16 Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet DK0714897T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP22510093 1993-08-18
JP28161393 1993-10-15
JP28567793 1993-10-21
US08/165,880 US5389620A (en) 1993-08-18 1993-12-14 Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
JP8591494 1994-03-30
PCT/JP1994/001357 WO1995005374A1 (fr) 1993-08-18 1994-08-16 Derive de cyclopentene heteroaromatique fusionne ayant une activite antagoniste de l'endotheline

Publications (1)

Publication Number Publication Date
DK0714897T3 true DK0714897T3 (da) 2001-03-19

Family

ID=27525184

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94922382T DK0714897T3 (da) 1993-08-18 1994-08-16 Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet

Country Status (12)

Country Link
EP (1) EP0714897B1 (da)
JP (1) JP2847969B2 (da)
CN (1) CN1049219C (da)
AT (1) ATE199151T1 (da)
AU (1) AU675870B2 (da)
CA (1) CA2169737C (da)
DE (1) DE69426698T2 (da)
DK (1) DK0714897T3 (da)
ES (1) ES2156157T3 (da)
GR (1) GR3035620T3 (da)
PT (1) PT714897E (da)
WO (1) WO1995005374A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545031B1 (en) 1995-08-02 2003-04-08 Smithkline Beecham Corporation Endothelin receptor antagonists
AU6646396A (en) * 1995-08-02 1997-02-26 Smithkline Beecham Corporation Endothelin receptor antagonists
US6162932A (en) * 1995-11-08 2000-12-19 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
US6080862A (en) * 1995-11-08 2000-06-27 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
AU7677496A (en) * 1995-11-08 1997-05-29 Smithkline Beecham Corporation Stereoselective synthesis of endothelin receptor antagonists
EA003587B1 (ru) * 1996-04-04 2003-06-26 Баниу Фармасьютикал Ко., Лтд. Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина
AU711936B2 (en) * 1996-08-09 1999-10-28 Banyu Pharmaceutical Co., Ltd. Stereoselective deoxygenation reaction
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
PT1009743E (pt) 1997-09-05 2004-09-30 Warner Lambert Co Certos antagonistas da endotelina a base de dioxido de benzotiazina e processos para a sua preparacao
AU742423B2 (en) * 1998-01-21 2002-01-03 Msd K.K. Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
US6410554B1 (en) 1998-03-23 2002-06-25 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
AU3011299A (en) * 1998-03-23 1999-10-18 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
AU2002331509B2 (en) 2001-10-19 2007-12-06 Aurinia Pharmaceuticals Inc. Synthesis of cyclosporin analogs
US20060089503A1 (en) * 2002-12-27 2006-04-27 Kaneka Corporation Processes for producing optically active 2-thiomethyl-3-phenylpropionic acid derivative and for producing intermediate therefor
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
EP1729749A2 (en) 2004-03-17 2006-12-13 Novartis AG Use of renin inhibitors in therapy
AR080683A1 (es) 2010-03-16 2012-05-02 Novartis Ag Composiciones farmaceuticas de aliskiren y metodos de administracion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59190956A (ja) * 1983-04-15 1984-10-29 金 明儒 ロカグラマイド化合物
US4845129A (en) * 1988-03-14 1989-07-04 Sandoz Pharm. Corp. Diaryl substituted cyclopentane and cyclopentene derivatives
DK0612244T3 (da) * 1991-11-05 2002-01-14 Smithkline Beecham Corp Endothelinreceptorantagonister
JP4066571B2 (ja) * 1999-02-17 2008-03-26 株式会社デンソー 携帯型光学情報読取り装置

Also Published As

Publication number Publication date
DE69426698T2 (de) 2001-08-16
CN1049219C (zh) 2000-02-09
WO1995005374A1 (fr) 1995-02-23
GR3035620T3 (en) 2001-06-29
JP2847969B2 (ja) 1999-01-20
EP0714897A1 (en) 1996-06-05
AU675870B2 (en) 1997-02-20
AU7351194A (en) 1995-03-14
DE69426698D1 (de) 2001-03-22
ES2156157T3 (es) 2001-06-16
CN1129448A (zh) 1996-08-21
CA2169737A1 (en) 1995-02-23
CA2169737C (en) 2003-04-15
EP0714897B1 (en) 2001-02-14
PT714897E (pt) 2001-05-31
EP0714897A4 (en) 1996-11-20
ATE199151T1 (de) 2001-02-15

Similar Documents

Publication Publication Date Title
DK0714897T3 (da) Ring-kondenseret heteroaromatisk cyclopentenderivat med endothelinantagonist-aktivitet
DE3781080T2 (de) 2-substituierte-e-kondensierte(1,2,4)triazolo-(1,5-c)pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
ES2059825T3 (es) Nuevos inhibidores de agregacion plaquetaria.
DE69321525T2 (de) Morphinan-derivate und medizinische verwendung
DK586588A (da) Terapeutiske heterocycliske forbindelser
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
DK0454651T3 (da) Hidtil ukendte blodpladeaggregeringsinhibitorer
DE69505968T2 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
TR24332A (tr) Fungisid olarak etkili akrilik asit tuerevleri
ES2043807T3 (es) Compuestos anticancer.
HUP0203976A2 (hu) Adenozin a3 receptor antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
GB1530768A (en) 2-substituted-4-amino-6,7-dimethoxyquinazolines
ES8708136A1 (es) Procedimiento para la obtencion de derivados de acido barbiturico
IT1216522B (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
ES2053079T3 (es) Piridazinaminas con actividad anti-rinoviral.
GB1337506A (en) Oxobenzofuran carboxamide anti-inflammatory agents
DE69002852T2 (de) Thioformamidderivate.
ES8201541A1 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
DE69018741D1 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
FI894424A (fi) Acylderivat av dianhydrohexitoler.
TH11541EX (th) อนุพันธ์ซับสทิทิวเทดกัวนิดีนชนิดใหม่, การเตรียมและการใช้สารเหล่านั้น